Month: November 2016

• November 28, 2016
• Other Treatments

Photodynamic Therapy with TOOKAD®

A new approach to focal treatment for prostate cancer has made its entrance onto the world stage and has patients talking. It is called photodynamic therapy (photo for light, dynamic for action) or PDT. It involves administering a light-sensitive chemical called TOOKAD® by a 10-minute IV injection, which is quickly taken up in the prostate keep reading

• November 24, 2016
• Imaging & mpMRI

Men Enthusiastically Want It

No, the title does not refer to sex, a Ferrari, a promotion, or winning the lottery. It’s a quote from Dr. Robert Nam from Toronto’s Sunnybrook Health Sciences Centre about the number of applicants for a clinical study of using 3T MRI to screen for prostate cancer (PCa).[i] There were 50 openings, but 300 applicants. keep reading

• November 14, 2016
• Other Treatments

Treatment Billboards: Half Truths in Advertising?

A newly available prostate cancer treatment has made Kaiser Permanente, one of the largest not-for-profit health plans, sit up and take notice. On October 4, 2016, the life sciences news service StatNews featured an article by Kaiser News staffer Julie Appleby, “Billboards and Websites Push Costly Prostate Cancer Treatment With Unknown Long-Term Benefits.”[i] The treatment keep reading

• November 3, 2016
• Imaging & mpMRI

Multiparametric MRI Shows Safety of Testosterone Replacement During Active Surveillance

Testosterone has important benefits for men. When it’s at a normal level, it helps develop muscle mass, decrease fat, avoid depression, keep bones strong, maintain libido, improve erections, and may help reduce risks of cardiovascular and cognitive disease. However, about 40% of men over the age of 45 have symptoms of reduced blood levels of keep reading